Gyre Therapeutics OverviewGyre Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for GYRE.
Quarterly EBIT
-$9.36M
↓ 511.57% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$27.73M
↑ 163.14% YoY
Trailing 12 months ending Mar 31, 2026
Gyre Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for GYRE.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026